GlassScriptPhysician profile
Helen Liu
NPI 1801022876
$3,945.18
in general payments reported to CMS, 2019-2025
18 companies · $806 in 2025
The $806 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $399 · 2021: $687 · 2022: $184 · 2023: $549 · 2024: $857 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,212.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,590.92 | 2019-2025 | |
| Janssen Biotech, INC. | $633.80 | 2024-2025 | Tremfya, Simponi, Stelara |
| Lilly USA, LLC | $423.51 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $318.30 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $244.69 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $120.39 | 2024-2025 | |
| Ucb, INC. | $113.26 | 2024 | Bimzelx |
| Helsinn Therapeutics (U.S.), INC. | $92.92 | 2020-2021 | |
| Incyte Corporation | $69.74 | 2023 | Opzelura |
| Genzyme Corporation | $69.45 | 2021-2025 | |
| Amgen INC. | $65.69 | 2020-2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $65.53 | 2023 | Ilumya |
| Galderma Laboratories, L.P. | $38.20 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $26.96 | 2021-2022 | |
| Smith+Nephew, INC. | $19.48 | 2025 | Grafix Pl |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.20 | 2021 | |
| Almirall LLC | $18.03 | 2019 | |
| Vyne Pharmaceuticals INC. | $15.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.